FundedIQ
Biotechnology

QuantuMDx Group: Funding, Investors & Team (Oct 2026)

QuantuMDx Group is a young and vibrant medical devices company developing hand-held and portable low cost diagnostic & genomic sequencing platforms capable of supporting the delivery of personalised medicine across both developed and developing nations.

quantumdx.com LinkedIn Newcastle Upon Tyne, United Kingdom 101-250 employees
Biotechnology Genetics Health Care Pharmaceutical
Total raised
$20.3M
Rounds
1
Latest
Undisclosed round
Nov 2021

QuantuMDx Group has raised $20.3M across 1 funding round on record, the most recent an undisclosed round of $20.3M announced in Nov 2021.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

QuantuMDx Group Company Profile and Key Stats

Total funding raised
$20.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$20.3M in Nov 2021
Employees
101-250
reported band
Headquarters
Newcastle Upon Tyne, United Kingdom

Latest funding round on record: Nov 2021.

QuantuMDx Group Funding Rounds

Date
Round
Amount
Undisclosed round
$20.3M

QuantuMDx Group Founders and Leadership Team

Name
Role
Contact
Jonathan O'Halloran
CEO
Locked

Contact details for the QuantuMDx Group team: 1 of 1 has an email address on file.

Start 14-day free trial →

QuantuMDx Group Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M

QuantuMDx Group's latest round of $20.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like QuantuMDx Group in Biotechnology and Newcastle Upon Tyne

Companies Similar to QuantuMDx Group

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

QuantuMDx Group Funding FAQs

What does QuantuMDx Group do?

QuantuMDx Group is a young and vibrant medical devices company developing hand-held and portable low cost diagnostic & genomic sequencing platforms capable of supporting the delivery of personalised medicine across both developed and developing nations.

How much funding has QuantuMDx Group raised?

QuantuMDx Group has raised $20.3M across 1 round on record. The most recent is an undisclosed round of $20.3M announced in Nov 2021.

When did QuantuMDx Group last raise funding?

QuantuMDx Group's most recent funding round on record is an undisclosed round of $20.3M, announced in Nov 2021.

Who is the CEO of QuantuMDx Group?

Jonathan O'Halloran is listed as CEO at QuantuMDx Group.

Where is QuantuMDx Group headquartered?

QuantuMDx Group is based in Newcastle Upon Tyne, United Kingdom.

How many employees does QuantuMDx Group have?

QuantuMDx Group is in the 101-250 employee band.

How does QuantuMDx Group's funding compare to other Biotechnology startups?

QuantuMDx Group's latest round of $20.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's QuantuMDx Group Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for QuantuMDx Group is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.